| 1 |
35192518 | Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients. | 2022 Jan 31 |
2 |
| 2 |
35443454 | Role of Potential Biomarkers in Management and Prognosis of Corona Virus Disease. | 2022 Apr |
1 |
| 3 |
33497271 | Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis. | 2021 Nov |
3 |
| 4 |
34588979 | The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis. | 2021 |
2 |
| 5 |
31520587 | A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease. | 2020 Jan |
1 |
| 6 |
32503662 | Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. | 2020 Jun 5 |
1 |
| 7 |
32859477 | Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. | 2020 Dec |
1 |
| 8 |
30603640 | Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus. | 2018 Dec |
1 |